As PDE4B inhibition has been shown to be beneficial in alleviating neurodegeneration in AD, we propose that preemptive PDE4B inhibition will suppress the observed high levels of synapse loss seen in APPswe/PS1dE9 mice. Here, PDE4B is linked to Alzheimer disease.